Novavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. 

CEO
John C.s Jacobs
CEOJohn C.s Jacobs
Employees
952
Employees952
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
952
Employees952

NVAX Key Statistics

Market cap
1.41B
Market cap1.41B
Price-Earnings ratio
4.38
Price-Earnings ratio4.38
Dividend yield
Dividend yield
Average volume
4.17M
Average volume4.17M
High today
$8.50
High today$8.50
Low today
$8.46
Low today$8.46
Open price
$7.87
Open price$7.87
Volume
56.04K
Volume56.04K
52 Week high
$10.64
52 Week high$10.64
52 Week low
$5.01
52 Week low$5.01

Stock Snapshot

Novavax(NVAX) stock is priced at $8.46, giving the company a market capitalization of 1.41B. It carries a P/E multiple of 4.38.

On 2026-01-14, Novavax(NVAX) stock traded between a low of $8.46 and a high of $8.50. Shares are currently priced at $8.46, which is 0.0% above the low and -0.5% below the high.

Novavax(NVAX) shares are trading with a volume of 56.04K, against a daily average of 4.17M.

In the last year, Novavax(NVAX) shares hit a 52-week high of $10.64 and a 52-week low of $5.01.

In the last year, Novavax(NVAX) shares hit a 52-week high of $10.64 and a 52-week low of $5.01.

NVAX News

Simply Wall St 4h
Improved Revenues Required Before Novavax, Inc. Stock's 32% Jump Looks Justified

Novavax, Inc. ( ) shareholders are no doubt pleased to see that the share price has bounced 32% in the last month, although it is still struggling to make up re...

Improved Revenues Required Before Novavax, Inc. Stock's 32% Jump Looks Justified
TipRanks 2d
Novavax Outlines New Growth Strategy and Partnerships

Claim 70% Off TipRanks Premium Novavax ( (NVAX) ) has provided an announcement. Novavax plans to provide investors with strategic and business updates on Janu...

Simply Wall St 6d
Why Novavax Is Up 9.2% After Singapore Backs Nuvaxovid And Analysts Hike Estimates

In recent weeks, Novavax reported mixed quarterly results, with revenue exceeding analyst expectations by a very large margin even as earnings per share came in...

Why Novavax Is Up 9.2% After Singapore Backs Nuvaxovid And Analysts Hike Estimates

Analyst ratings

50%

of 10 ratings
Buy
50%
Hold
20%
Sell
30%

More NVAX News

Simply Wall St 7d
Is Novavax A Potential Opportunity After Recent Vaccine Market Volatility?

If you are wondering whether Novavax at US$7.44 is a bargain or a value trap, this article will help you size up what the current price might be implying about...

Is Novavax A Potential Opportunity After Recent Vaccine Market Volatility?

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .